|
⚲
|
| Keyboard |
| Broadwood Capital Inc
✚
|
|
|---|---|
| CRD # | 159286 |
| SEC # | 801-73853 |
| CIK # | 0001278387 |
| AUM | 1,711.4 M (2026-03-31) |
| Employees | 6 (83% Investors, 0% Brokers) |
| Fees | |
| Minimum | |
| Phone | 212-508-5735 |
| Address | 156 West 56th Street New York, NY 10019 |
| Source | [IAPD] [EDGAR] [Website] |
| Total AUM ($M) |
|---|
| Fees and Compensation — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 5. Fees and Compensation Asset-Based Compensation Each investor in BPLP is charged a management fee based on the value of such investor’s capital account at an annual rate of 1% per annum (the “Management Fee”), as described in the Partnership’s Confidential Private Placement Memorandum. The Management Fee is charged in an amount equal to one quarter of 1% (0.25%) each quarter in arrears. If the investment management agreement between BPLP and the Adviser is terminated during a quarter, the Management Fee will be calculated as of the termination date and prorated for the number of days during the quarter in which the investment management arrangement was in effect. The Management Fee may be reduced or waived at the discretion of the Adviser, as described in the Partnership’s Confidential Private Placement Memorandum. Incentive-Based Compensation The Adviser also receives a quarterly incentive allocation (“Quarterly Incentive Allocation”) equal to 20% of the net capital appreciation (both realized and unrealized) of the assets of the Partnership, subject to a “high water mark” calculation. The Quarterly Incentive Allocation may be reduced or waived at the discretion of the Adviser, as described in the Partnership’s Confidential Private Placement Memorandum. Fixed Fee The Non-Discretionary Advisory Account pays the Adviser a quarterly fee of $75,000 (the “Fixed Fee”). The Fixed Fee is paid in advance. If the investment advisory agreement between the Non-Discretionary Advisory Account and the Adviser is terminated during the quarter, the Fixed Fee will be prorated for the number of days during the quarter in which the investment advisory agreement was in effect. The Adviser does not deduct the Fixed Fee from the Non-Discretionary Advisory Account. Rather, the Adviser bills the Non-Discretionary Advisory Account. The Fixed Fee is negotiated with the Non-Discretionary Advisory Account. Operational Expenses In addition to paying the Management Fee and the Quarterly Incentive Allocation, the Partnership will be responsible for all of the ordinary and necessary expenses of its operation including, without limitation, brokerage commissions, insurance premiums, legal and auditing expenses, consultant and other service provider expenses, and similar ongoing operational expenses. Please refer to Item 12 of this Firm Brochure for a discussion of the Adviser’s brokerage practices. The Partnership assets may be invested in money market mutual funds, ETFs or other registered investment companies. In these cases, the Partnership will bear its pro rata share of the investment management fee and other fees of these investment funds, which are in addition to the Management Fee paid to the Adviser. The Adviser guarantees that the total expenses of the Partnership for any fiscal year, exclusive of the Management Fee, taxes, interest, brokerage fees and any extraordinary non-recurring expenses (other than organizational and syndication expenses), including litigation affecting the Partnership, will not exceed, and the Adviser undertakes to refund to the Partnership any amount by which such expenses will exceed, one percent (1%) of the Partnership's annual average net assets, such average net assets to be computed by averaging the net assets as of the end of each fiscal quarter. All expenses of the Non-Discretionary Advisory Account (with the exception of services of the Adviser which shall be rendered at the Adviser’s own expense), including, but not limited to expenses relating to the execution of investments, shall be paid by the Non-Discretionary Advisory Account. |
| Account Minimums and Types of Clients — Form ADV Part 2A (3/31/2026) [Brochure] |
|---|
Item 7. Types of Clients The Adviser’s clients consist of the Partnership and the Non-Discretionary Advisory Account, each of which are private investment funds. The Adviser, however, is not precluded from advising types of clients that are not listed above. Under the terms of BPLP’s Limited Partnership Agreement, the minimum initial investment for BPLP is $250,000, subject to waiver at the discretion of the Adviser. In recent years, the Partnership generally has accepted initial investments when there is a commitment to invest at least $1,000,000. The Adviser does not anticipate accepting any other clients in addition to BPLP and the Non-Discretionary Advisory Account. |
| Sector | Form 13F Holdings | Value ($B) | |
|---|---|---|---|
| Hansen Natural Corp | 0.6 | ||
| Staar Surgical Co | 0.3 | ||
| Taser International Inc | 0.3 | ||
| Biotime Inc | 0.1 | ||
| Oncocyte Corp | 0.0 | ||
| Holdings by Sector ($B) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| HF | Broadwood Partners LP | [2012-02-14] | 109.6 M | 1,711.4 M |
| Filed 2025-08-05 (D/A) · Exemption 506(b), 3(c), 3(c)(1) · Minimum $250,000 · Remaining Indefinite · Duration More than one year · Net Assets Decline to Disclose | ||||
| AUM Breakdown | Accounts | AUM ($M) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 2 | 1,711.4 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 1 | 1,711.4 |
| By Discretionary | ||
| Discretionary | 1 | 1,711.4 |
| Non-Discretionary | 0 | 0.0 |
| Total | 1 | 1,711.4 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 1,711.4 | |
| Total | 1 | 1,711.4 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Neal Bradsher | Executive Officer | 7 | 2 | |
| Broadwood Capital Inc | Executive Officer | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 13F-HR | [0001278387] | |
| 3 | [0001278387] | |
| 4 | [0001278387] |
| Firm Profile (Form ADV) | |
|---|---|
| Discretionary AUM | $0.4B |
| Clients | 1 |
| Serves | Institutional |
| Fund Types | Hedge Fund |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Staar Surgical Co STAA
Common Stock
|
2026-03-13 | Buy | 316,017 | $18.62 | 5,884,237 |
|
Staar Surgical Co STAA
Common Stock
|
2026-03-13 | Buy | 0 | $0.00 | |
|
Staar Surgical Co STAA
Common Stock
|
2026-03-12 | Buy | 0 | $0.00 | |
|
Staar Surgical Co STAA
Common Stock
|
2026-03-12 | Buy | 299,432 | $18.12 | 5,425,708 |
|
Staar Surgical Co STAA
Common Stock
|
2026-03-11 | Buy | 54,764 | $17.52 | 959,465 |
|
Staar Surgical Co STAA
Common Stock
|
2026-03-11 | Buy | 0 | $0.00 | |
|
Oncocyte Corp IMDX
Common Stock, no par value
|
2026-02-10 | Buy | 0 | $0.00 | |
|
Oncocyte Corp IMDX
Common Stock, no par value
|
2026-02-10 | Buy | 521,739 | $5.75 | 2,999,999 |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-09 | Buy | 27,485 | $22.05 | 606,044 |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-09 | Buy | 0 | $0.00 | |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-08 | Buy | 3,240 | $21.94 | 71,086 |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-08 | Buy | 0 | $0.00 | |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-07 | Buy | 66,467 | $22.00 | 1,462,274 |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-07 | Buy | 0 | $0.00 | |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-06 | Buy | 150,000 | $22.38 | 3,357,000 |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-06 | Buy | 0 | $0.00 | |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-06 | Buy | 186,946 | $21.01 | 3,927,735 |
|
Staar Surgical Co STAA
Common Stock
|
2026-01-06 | Buy | 0 | $0.00 | |
|
Staar Surgical Co STAA
Common Stock
|
2025-11-21 | Buy | 0 | $0.00 | |
|
Staar Surgical Co STAA
Common Stock
|
2025-11-21 | Buy | 797,486 | $27.86 | 22,217,960 |
| showing 20 of 200 most recent transactions | |||||
| Comparable Firms | State | AUM |
|---|---|---|
|
Caius Capital LLP
✚
|
1,751.0 M | |
|
Amity Ventures LLC
✚
|
CA | 1,737.5 M |
|
Commonwealth Credit Advisors LLC
✚
|
FL | 1,730.6 M |
|
Engine Capital Management LP
✚
|
NY | 1,725.5 M |
|
RK Capital Management LLC
✚
|
FL | 1,719.0 M |
|
North Peak Capital Management LLC
✚
|
NY | 1,703.0 M |
|
Prescott General Partners LLC
✚
|
FL | 1,694.9 M |
|
Parsifal Capital Management LP
✚
|
CT | 1,694.4 M |
|
Affinity Asset Advisors LLC
✚
|
NY | 1,691.1 M |
|
ADAR1 Capital Management LLC
✚
|
TX | 1,675.1 M |